
Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teens.

Michelle M. Maresca, MD, Medical Director for Pediatric Obesity Medicine, Joseph M. Sanzari Children's Hospital at Hackensack Meridian Hackensack University Medical Center

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teens.

Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.

Experts outline when primary care should manage PMOS versus refer, and why insulin resistance matters.

Experts detail how PMOS diagnostic criteria differ in adolescents, where ovarian ultrasound doesn't apply.

Heather Appelbaum, MD, FACOG, Melanie Cree, MD, PhD, and Michelle Maresca, MD, react to the renaming of PCOS to PMOS in the first of 5 episodes of this Special Report series discussing the new name.